Stephens Investment Management Group LLC increased its holdings in Amprius Technologies, Inc. (NYSE:AMPX – Free Report) by 33.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,441,698 shares of the company’s stock after acquiring an additional 358,791 shares during the period. Stephens Investment Management Group LLC’s holdings in Amprius Technologies were worth $11,375,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Amprius Technologies by 9.5% during the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock valued at $56,245,000 after purchasing an additional 616,037 shares during the last quarter. Invesco Ltd. raised its stake in shares of Amprius Technologies by 113.3% in the third quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock worth $25,031,000 after purchasing an additional 1,263,846 shares during the last quarter. UBS Group AG raised its stake in shares of Amprius Technologies by 35.5% in the fourth quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock worth $16,561,000 after purchasing an additional 549,892 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Amprius Technologies by 1,117.9% in the third quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock valued at $20,450,000 after purchasing an additional 1,784,291 shares in the last quarter. Finally, Voloridge Investment Management LLC bought a new position in shares of Amprius Technologies in the third quarter valued at approximately $19,737,000. Institutional investors own 5.04% of the company’s stock.
Insider Transactions at Amprius Technologies
In related news, CTO Constantin Ionel Stefan sold 25,366 shares of Amprius Technologies stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $257,718.56. Following the completion of the sale, the chief technology officer owned 723,330 shares of the company’s stock, valued at approximately $7,349,032.80. This trade represents a 3.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kang Sun sold 1,500,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total value of $23,865,000.00. Following the completion of the sale, the director owned 1,342,400 shares in the company, valued at $21,357,584. This represents a 52.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 2,539,829 shares of company stock worth $42,323,376 over the last quarter. 5.10% of the stock is currently owned by corporate insiders.
Amprius Technologies Stock Down 0.1%
Amprius Technologies (NYSE:AMPX – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. The firm had revenue of $28.54 million during the quarter, compared to analysts’ expectations of $25.72 million. As a group, equities analysts expect that Amprius Technologies, Inc. will post -0.07 EPS for the current year.
Wall Street Analyst Weigh In
AMPX has been the subject of several recent research reports. Needham & Company LLC reiterated a “buy” rating and set a $20.00 price target on shares of Amprius Technologies in a report on Tuesday, March 10th. Northland Securities set a $24.00 price objective on Amprius Technologies in a research note on Monday, May 11th. Cantor Fitzgerald lifted their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a research note on Friday, March 6th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a report on Monday, April 20th. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Amprius Technologies presently has an average rating of “Moderate Buy” and an average target price of $20.25.
View Our Latest Analysis on AMPX
Amprius Technologies Profile
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Further Reading
- Five stocks we like better than Amprius Technologies
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Want to see what other hedge funds are holding AMPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amprius Technologies, Inc. (NYSE:AMPX – Free Report).
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
